Matteo Giovanni Della Porta

37PUBLICATIONS
389CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsRegenerative medicine (incl. stem cells)Predictive and prognostic markersMedical mycologyMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Oct 14, 2026
Immune and cellular determinants of response to HMA-venetoclax regimens in acute myeloid leukemia.

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Jul 30, 2026
Assessment of the IPSS-M in chronic myelomonocytic leukemia.

|Jul 17, 2026
Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

|Jun 24, 2026
Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

|Mar 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.

Luca Lanino, Anthony M Hunter, Nico Gagelmann

Pageof 7

Frequent Collaborators

16 joint publications

Valeria Santini

15 joint publications

Uwe Platzbecker

13 joint publications

Luca Lanino

12 joint publications

Rami S Komrokji